India has gone from fund managers’ top Asian stock market pick to their least preferred in just three months amid US ...

Indian stocks have declined since July, with the Nifty down 3.6% and trading at a three-month low. In contrast, major Asian ...

Eli Lilly is now selling Mounjaro GLP-1 weight loss drugs in India. Rival Novo Nordisk began Indian Wegovy sales in June.

The new integration gives users access to share prices, market news, and corporate updates from both the Bombay Stock ...

India’s benchmark indexes closed in the green on Wednesday, led by gains in auto and financial stocks, as softer U.S. retail ...

In the most recent fund manager survey, 30% said they are underweight on India, followed by 20% for Thailand and 10% for ...

India's markets regulator on Wednesday proposed to include new market practises such as algorithmic trading and proprietary trading in its master regulations. At present, such activities are covered ...

Perplexity, which aspires to disrupt Google’s flagship search engine, has been focusing on incorporating local content to ...

The BSE Sensex settled 304.32 points or 0.38% higher at 80,539.91 levels, while Nifty50 ended 131.95 points or 0.54% higher ...

Indian equity benchmarks inched lower on Tuesday as a drop in financials weighed ahead of key U.S. and domestic inflation ...

The National Stock Exchange of India, which is larger than the BSE by transaction value, has now taken Hong Kong’s place as the seventh-largest bourse.

India has gone from fund managers’ top Asian stock market pick to their least preferred in just three months amid US ...